Meet Selexis During Key Industry Conferences to Learn About the Latest Innovations in Cell Line Development

Selexis SA, a JSR Life Sciences company, today announced that business and scientific leaders from the company will participate at key in-person and virtual scientific and life sciences industry partnering conferences through December 2021.

“Face-to-face meetings with the scientific community, as well as current and future customers and partners, offer significant learning and networking opportunities that help to fuel our future growth and expertise as we work to advance medicines to the clinic and, ultimately, to patients in need,” said Dirk Lange, chief executive officer at Selexis. “We are thrilled to mark our return to in-person meetings at PEGS Europe in Barcelona where much of the focus will be on those next-generation, difficult-to-express proteins – an area of cell line development in which Selexis excels and works to continually innovate.”

Following are opportunities to learn more about Selexis and its SUREtechnology Platform™ of innovative cell line development tools and modular technologies.

PEGS EUROPE Protein & Antibody Engineering Summit

2 – 4 November 2021, Hotel Arts Ritz Carlton; Barcelona, Spain (Virtual & In Person)

Selexis’ Alexandra Martiné, MSc, project leader, cell culture automation, will present “SUREtechnology Modular Approach For Expression Of Diverse Array Of Biomolecules” on Tuesday, 2 November at 4:35 p.m. CET. Additionally, Selexis is a conference sponsor and exhibitor (booth #401). For more information and to register, please visit: https://www.pegsummiteurope.com.

BIO Asia-Taiwan

4 – 7 November 2021 (In Person), Taipei Nangang Exhibition Center, Hall 2, 4F

To attend the conference or to participate in partnering discussions, please visit: https://expo.bioasiataiwan.com/en/

Festival of Biologics

9 – 11 November 2021, Congress Centre, Basel (In Person)

For more information and to register, please visit: https://www.terrapinn.com/conference/festival-of-biologics/

CPhI Worldwide

9 – 11 November 2021, Fiera Milano, Milan, Italy (In Person)

For more information and to register, please visit: https://www.cphi.com/en/home.html

BioFIT 2021

7 – 9 December 2021 (Virtual)

For more information and to register, please visit: https://www.biofit-event.com

INTERPHEX JAPAN 2021

8 December – 10 December 2021, Makuhari Messe, Japan (In Person)

For more information and to register, please visit: https://www.interphex.jp/en-gb.html

Antibody Engineering & Therapeutics

12 – 16 December 2021, Marriott Marquis San Diego (Virtual and In Person)

For more information and to register, please visit: https://informaconnect.com/antibody-engineering-therapeutics/

About Selexis SA

Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 146 drug candidates in preclinical and clinical development and the manufacture of eight commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks. More information is available at www.selexis.com.

FOR MORE INFORMATION

- Web www.selexis.com

- LinkedIn www.linkedin.com/company/selexis-sa

- Twitter www.twitter.com/SelexisSA

- Facebook www.facebook.com/SelexisSA

View source version on businesswire.com: https://www.businesswire.com/news/home/20211101005118/en/